960 The Ref on MSN

Oxford selects its word of the year; What is ‘rage bait’

While Dictionary.com already picked “67″ as its word of the year, the preeminent experts on language have chosen a different ...

Pharmaceuticals and Biotechnology Distribution Deals Trends Analysis Report 2025: Navigate Financial Terms and Payment Structures of Recent Distribution Deals

The "Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering.The report contains a comprehensive listing of distribution deals announced ...

Pharmaceuticals and Biotechnology Joint Venture Agreements Analysis Report 2025: Track Trends, Benchmark Valuations, and Access Detailed Contract Terms from 2016 Onward

The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of joint venture deals ...
Free Malaysia Today on MSN

‘We’re already living in sci-fi’: the neurotech revolution

From turning thoughts into words to allowing paralysed people to walk, neurotechnology has been gaining ground, raising hopes ...
Daily Express

Fears new Islamophobia definition could be used to water down terrorism laws

21:25, Mon, Oct 20, 2025 Updated: 21:28, Mon, Oct 20, 2025 Activists demanding an Islamophobia definition will use it to water down counter-terrorism policies and immigration rules, a scathing report ...
Yahoo Finance

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund launched on June ...
Ventura County Star

Dr. Loh: Why the cancellation of mRNA biotechnology funding matters

The U.S. Department of Health and Human Services (HHS) has canceled almost $500 million in funding for mRNA vaccine projects, alleging worries about safety and efficacy. They are winding down nearly ...
MarketWatch

Biotechnology Company Top Create Biotech Files for IPO

Top Create Biotech has filed for an initial public offering. The biotechnology company said Wednesday that it intends to list shares under the ticker symbol TCBG on the Nasdaq Capital Market. Top ...
Business Wire

MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, ...
Nasdaq

Earnings Outlook For Vir Biotechnology

Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement. Analysts estimate that Vir ...
csis.org

Understanding the National Security Commission on Emerging Biotechnology Report

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...